Denali Capital Acquisition Corp. - Class A

The momentum for this stock is not very good. Denali Capital Acquisition Corp. - Class A is not very popular among insiders. Tradey thinks it is not wise to invest in Denali Capital Acquisition Corp. - Class A.

News

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Bu

Globe Newswire Semnur Pharmaceuticals, Inc. ( Semnur ), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, Scilex ), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the SPAC ) announce the...\n more…

Denali Capital Acquisition Corp. Maneuvers for Business Combination

TipRanks Financial Blog Denali Capital Acquisition Corp. Class A (DECA) has shared an update. Denali Capital Acquisition Corp. issued a convertible promissory note to its sponsor, Denali C...\n more…

Denali Capital Acquisition Corp trading resumes

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Semnur Pharmaceuticals and Denali Capital Acquisition enter into a letter of intent for proposed business combination

Seeking Alpha - Healthcare Semnur Pharmaceuticals and Denali Capital Acquisition enter into a letter of intent for proposed business combination...\n more…

Denali Capital Acquisition Corp trading halted, news pending

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Co